BIO Should Use Political Clout Carefully, Outgoing President Feldbaum Urges
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotechnology industry should reserve its political "hammer" for key policy issues, such as intellectual property rights, unreasonable regulation and price controls, BIO's Feldbaum says in farewell address to trade association. BIO holds a formidable weapon, but "don't use it as a sledgehammer," Feldbaum advises.